Shares of GeneDx Holdings (WGS -38.27%) were plunging 42.9% as of 11:21 a.m. ET on Wednesday. The steep decline came after the genetic diagnostics company announced its 2025 first-quarter earnings before the market opened.GeneDx reported Q1 revenue of $87.1 million, up 42$79.5 million. What about GeneDx's bottom line? The company posted a Q1 net loss of $6.5 million based on generally accepted accounting principles (GAAP). Ho ...